From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

A review of recent trends and remaining challenges in bispecific antibody (bsAb) production has been published.

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

A new antibody therapy effectively protects monkeys from severe H5N1 avian flu, offering hope for a universal flu vaccine and ...

Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for ...

Antibody design to improve homogeneity and potential for development. Antibodies are a successful class of therapeutic agents, but many treaments remain costly, which may limit their use ...

The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...

In this article, we are going to take a look at where ImmunoPrecise Antibodies Ltd. (NASDAQ ... said that the company anticipates enabling the development of three key robots in the coming years ...